Humana Divests $900 Million Stake in End-of-Life Provider Gentiva
Humana has completed the divestment of its interest in Gentiva, a healthcare provider specializing in end-of-life care services. The transaction for this stake is valued at $900 million. This move represents a significant financial development for the prominent healthcare company.
Humana, a major entity in the healthcare sector, has divested its interest in Gentiva, a company known for providing end-of-life care services. This strategic transaction for Humana's stake in Gentiva has been valued at $900 million.
The divestment signifies a notable financial and strategic decision for Humana within the competitive healthcare market.
Advertisement
AdSense slot • inline
